IBMS/ECTS 2001 - PROGRAM and ABSTRACTS
HORMONES, INCLUDING ESTROGEN, VITAMIN D, PTHrP
Chairs: Gordon J. Strewler (West Roxbury, MA/USA),
René Rizzoli (Geneva/Switzerland)
Friday, June 8, 2001
14:00 - 15:00 Auditorium
- IN10
- Mechanism of Regulation of 25 OH D3-1alpha Hydroxylase
- Shigeaki Kato (Tokyo/Japan)
- IN11
- The Molecular Pharmacology of Estrogen Receptor Agonists, Antagonists and SERMs
- Donald P. McDonnell (Durham, NC/USA)
HORMONES, INCLUDING ESTROGEN, VITAMIN D, PTHrP
Chairs: Gordon J. Strewler (West Roxbury, MA/USA),
René Rizzoli (Geneva/Switzerland)
Friday, June 8, 2001
15:00 - 17:00 Auditorium
The abstract text of oral presentations (prefix OR) can be found in the Abstracts section. Click on the Abstract number.
- 15:00 OR35
- MALE MICE LACKING ESTROGEN RECEPTOR-b LOSE CANCELLOUS AND CORTICAL BONE FOLLOWING ORCHIDECTOMY
- H. Z. Ke*, T. A. Brown, K. L. Chidsey-Frink, H. Qi, D. T. Crawford, H. A. Simmons, D. N. Petersen, M. R. Allen, J. D. McNeish, D. D. Thompson
- Global Research and Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut, USA
- 15:12 OR36
- ESTROGEN INHIBITS ADIPOCYTIC DIFFERENTIATION OF BONE MARROW STROMAL CELLS THROUGH EITHER ESTROGEN RECEPTOR ALPHA OR BETA
- R. Okazaki*, D. Inoue, M. Shibata, M. Saika, S. Kido, Y. Sakamoto, T. Matsumoto
- Teikyo University, Ichihara, Japan; Tokushima University, Tokushima, Japan
- 15:24 OR37
- ESTROGEN DEFICIENCY CAUSES BONE LOSS THROUGH UPREGULATED T CELL PRODUCTION OF TNF ALPHA
- C. Roggia*, M. N. Weitzmann, S. Cenci, G. Toraldo, J. Kindle, R. Pacifici
- Division of Bone and Mineral Diseases Washington University School of Medicine, St. Louis MO, USA
- 15:36 OR38
- THE TRABECULAR BONE MINERAL DENSITY IS PRESERVED BOTH BY AN ACTIVATION OF THE ANDROGEN RECEPTOR AND BY AN ACTIVATION OF THE ESTROGEN RECEPTOR ALPHA IN MALE MICE
- S. Movérare*, M. K. Lindberg, S. Skrtic, J. Ĺ. Gustafsson, C. Ohlsson
- Department of Internal Medicine, Division of Endocrionology, Sahlgrenska University Hospital, Göteborg, Sweden; Department of Medical Nuitrition, Karolinska Institute, Novum, Huddinge, Sweden
- 15:48 OR39
- REGULATION AND FUNCTIONS OF VITAMIN D RECEPTOR SHUTTLING
- J. Barsony*, K. Prufer, C. Segovis
- Laboratory of Cell Biochemistry and Biology, NIDDK, NIH, USA
- 16:00 OR40
- VITAMIN D IS A NEGATIVE REGULATOR OF BONE FORMATION
- H. Tanaka*, K. Kinuta, N. Inoue, M. Shinohara, S. Kato, Y. Seino
- Okayama University Medical School, Okayama, Japan; University of Tokyo, Tokyo, Japan
- 16:12 OR41
- MECHANISMS OF BIPHASIC ANABOLIC AND CATABOLIC EFFECTS OF PARATHYROID HORMONE (PTH) ON BONE CELLS
- R. M. Locklin*, S. Khosla, B. L. Riggs
- Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
- 16:24 OR42
- PREVENTION OF ACUTE ISCHEMIC RENAL FAILURE BY TARGETED DELIVERY OF GROWTH FACTORS TO THE PROXIMAL TUBULE IN TRANSGENIC MICE: THE ROLES OF HEPATOCYTE GROWTH FACTOR AND PTH-RELATED PROTEIN
- N. M. Fiaschi-Taesch*, S. Santos, S. Van Why, P. Esbrit, J. J. Orloff, A. F. Stewart, A. Garcia-Ocana
- Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Division of Pediatric Nephrology, Yale University School of Medicine, New Haven, CT, USA; Fundación Jiménez Díaz, Madrid, Spain; Merck and Co, Rahway, NJ, USA
- 16:36 OR43
- THE SKELETAL EFFICACY OF STATINS DO NOT COMPARE WITH LOW-DOSE PARATHYROID HORMONE
- M. Sato*, A. Schmidt, H. Cole, S. Smith, E. Rowley, L. Ma
- Lilly Research Laboratories, Indianapolis IN, USA
- 16:48 OR44
- NOVEL CGRP/AMYLIN RECEPTOR FUNCTIONS OF THE HUMAN CALCITONIN RECEPTOR ISOTYPE 2 MODULATED BY ACCESSORY RECEPTOR-ACTIVITY-MODIFYING PROTEINS (RAMP)
- K. Leuthäuser*, R. Gujer, A. Aldecoa, R. A. McKinney, R. Muff, J. A. Fischer, W. Born
- Research Laboratory for Calcium Metabolism, University of Zurich, Klinik Balgrist, Zurich, Switzerland; Brain Research Institute, University of Zurich, Zurich, Switzerland
